Long-Term Management of Atopic Dermatitis: The Role of Tralokinumab

from TheBrief.Health · host TheBrief.Health

Six-year ECZTEND data show tralokinumab delivers sustained skin clearance, itch reduction, and consistent safety in atopic dermatitis, supporting long-term IL-13–targeted therapy as a durable management strategy.

What this episode covers

NOW PLAYING

0:00 1:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on February 24, 2026.

What is this episode about?

Can I download this TheBrief.Health episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!